Health
BioNTech/Pfizer vaccine found effective against Covid-19 variant – Financial Times
Laboratory-based study shows mutations were neutralised by antibodies in blood of vaccinated patients
The Covid-19 vaccine developed by BioNTech and Pfizer is likely to be effective against a rapidly spreading strain of the virus that was first discovered in the UK, a laboratory-based study by the companies has shown.
The variant, known as B.1.1.7, has a high number of mutations, which has led to concerns that could bypass the immune defences built up by vaccines being rolled out worldwide, a large proportion of which have been made by BioNTech and Pfizer.
However, researchers at BioNTech’s headquarters…
-
Noosa News20 hours agoThe grey backstreet of Brisbane’s Fortitude Valley where Arnie the missing dog was found dead in his owner Nathan McKeown’s black ute
-
Noosa News23 hours agoFuel tanker racing to unload in Darwin ahead of Tropical Cyclone Fina
-
Noosa News19 hours agoSeven key takeaways from the Queensland probe’s first week
-
General21 hours agoWaste from Perth set to be trucked out to York after WA minister approves landfill site